
Dermatology Times Spot Test: April 5, 2026
Key Takeaways
- Weekly Spot Test questions are positioned as a recurring tool to assess knowledge across core dermatology themes and fast-moving developments.
- This week’s focus centers on insights generated at the AAD Annual Meeting in Denver, leveraging conference momentum and topical relevance.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
Welcome to Dermatology Times' Spot Test.
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. We’re reflecting on a fantastic week in Denver spent at the
Do you have a set of quiz questions to share? Contact editor Marie Bosslett at
According to Reid Waldman, MD, co-founder and CEO of Veradermics, what is a key theoretical advantage of extended-release minoxidil at the hair follicle level?
Chinweike Ukomadu, MD, PhD, therapeutic area head for GI and inflammation at Takeda Pharmaceuticals, outlined phase 3 trials, comparing zasocitinib with placebo and which active comparator?
Which anatomical area showed notable treatment success in the phase 2 INTEGUMENT-INFANT study of roflumilast, according to dermatologist and chief medical officer of Aructis Biotherapeutics, Patrick Burnett, MD, PhD?














